Found: 29
Select item for more details and to access through your institution.
Development and validation of an individualized and weighted Myeloma Prognostic Score System (MPSS) in patients with newly diagnosed multiple myeloma.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 4, p. 523, doi. 10.1002/ajh.27207
- By:
- Publication type:
- Article
Aberrant metabolic processes promote the immunosuppressive microenvironment in multiple myeloma.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.1077768
- By:
- Publication type:
- Article
P-174: Clinical study of bortezomib-based regimens of BCD, PAD and VDD for newly diagnosed multiple myeloma – an analysis of 400 cases in a single center of China.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S131, doi. 10.1016/S2152-2650(21)02301-6
- By:
- Publication type:
- Article
Subtype Distribution, Clinical Features, and Survival in B-cell Chronic Lymphoproliferative Disorders in China: A Review of 1592 Cases.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Clinical Characteristics, Survival Outcomes and prognosis in 82 Immunoglobulin D Multiple Myeloma Patients: A Retrospective Single-Center Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e304, doi. 10.1016/j.clml.2019.09.499
- By:
- Publication type:
- Article
Real-world Outcomes of Chinese patients with high-risk Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e222, doi. 10.1016/j.clml.2019.09.369
- By:
- Publication type:
- Article
The prognostic impact of dynamic changing of cytogenetic abnormalities under the treatment options in multiple myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e221, doi. 10.1016/j.clml.2019.09.368
- By:
- Publication type:
- Article
Monitoring the cytogenetic architecture of minimal residual plasma cells indicates the therapy-induced clonal selection in multiple myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e187, doi. 10.1016/j.clml.2019.09.313
- By:
- Publication type:
- Article
Multiple high-risk cytogenetic aberrations confer a progressively negative impact on survivals of newly diagnosed myeloma patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e83, doi. 10.1016/j.clml.2019.09.132
- By:
- Publication type:
- Article
IgH translocations with undefined partners are associated with superior outcome in multiple myeloma patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e82, doi. 10.1016/j.clml.2019.09.131
- By:
- Publication type:
- Article
The prognostic value of 1q21 gain does not rely on the copy numbers, clone size and concurrence with t(4;14).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e62, doi. 10.1016/j.clml.2019.09.097
- By:
- Publication type:
- Article
Tolerance, Kinetics, and Depth of Response for Subcutaneous Versus Intravenous Administration of Bortezomib Combination in Chinese Patients With Newly Diagnosed Multiple Myeloma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Multiple myeloma–derived miR‐27b‐3p facilitates tumour progression via promoting tumour cell proliferation and immunosuppressive microenvironment.
- Published in:
- Clinical & Translational Medicine, 2023, v. 13, n. 1, p. 1, doi. 10.1002/ctm2.1140
- By:
- Publication type:
- Article
Targeting stem cell niche can protect hematopoietic stem cells from chemotherapy and G-CSF treatment.
- Published in:
- Stem Cell Research & Therapy, 2015, v. 6, p. 1, doi. 10.1186/s13287-015-0164-4
- By:
- Publication type:
- Article
Targeting stem cell niche can protect hematopoietic stem cells from chemotherapy and G-CSF treatment.
- Published in:
- Stem Cell Research & Therapy, 2015, v. 6, n. 1, p. 1, doi. 10.1186/s13287-015-0164-4
- By:
- Publication type:
- Article
Early relapse within 18 months is a powerful dynamic predictor for prognosis and could revise static risk distribution in multiple myeloma.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 3, p. 421, doi. 10.1002/cncr.35056
- By:
- Publication type:
- Article
Undetectable minimal residual disease is an independent prognostic factor in splenic marginal zone lymphoma.
- Published in:
- British Journal of Haematology, 2021, v. 194, n. 5, p. 862, doi. 10.1111/bjh.17703
- By:
- Publication type:
- Article
Synthesis of Hydrophobic Polymeric Cryogels with Supermacroporous Structure.
- Published in:
- Macromolecular Materials & Engineering, 2016, v. 301, n. 6, p. 659, doi. 10.1002/mame.201500454
- By:
- Publication type:
- Article
Gemcitabine‐based conditioning compared to BEAM/BEAC conditioning prior to autologous stem cell transplantation for non‐Hodgkin lymphoma: No difference in outcomes.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 2, p. 1, doi. 10.1002/cam4.6965
- By:
- Publication type:
- Article
Multiple myeloma hinders erythropoiesis and causes anaemia owing to high levels of CCL3 in the bone marrow microenvironment.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-77450-y
- By:
- Publication type:
- Article
Real-world treatment patterns, discontinuation and clinical outcomes in patients with B-cell lymphoproliferative diseases treated with BTK inhibitors in China.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1184395
- By:
- Publication type:
- Article
Minimal residual disease status improved the response evaluation in patients with Waldenström’s macroglobulinemia.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1171539
- By:
- Publication type:
- Article
Immunophenotypic profile defines cytogenetic stability and unveils distinct prognoses in patients with newly-diagnosed multiple myeloma (NDMM).
- Published in:
- Annals of Hematology, 2024, v. 103, n. 4, p. 1305, doi. 10.1007/s00277-023-05573-z
- By:
- Publication type:
- Article
Adenopathy and extensive skin patch overlying a plasmacytoma (AESOP) syndrome: a case report and literature review.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 1, p. 339, doi. 10.1007/s00277-023-05465-2
- By:
- Publication type:
- Article
Impact of residual tumor cells in the stem cell collection on multiple myeloma patients receiving autologous stem cell transplantation.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 11, p. 3195, doi. 10.1007/s00277-023-05427-8
- By:
- Publication type:
- Article
Purine nucleoside analogs plus rituximab are an effective treatment choice for hairy cell leukemia-variant.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 6, p. 1201, doi. 10.1007/s00277-022-04795-x
- By:
- Publication type:
- Article
Multiple myeloma patients with low proportion of circulating plasma cells had similar survival with primary plasma cell leukemia patients.
- Published in:
- Annals of Hematology, 2015, v. 94, n. 2, p. 257, doi. 10.1007/s00277-014-2211-0
- By:
- Publication type:
- Article
Single-cell profiles reveal tumor cell heterogeneity and immunosuppressive microenvironment in Waldenström macroglobulinemia.
- Published in:
- Journal of Translational Medicine, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12967-022-03798-6
- By:
- Publication type:
- Article
Longitudinal genetically detectable minimal residual disease by fluorescence in situ hybridization confers a poor prognosis in myeloma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, v. 16, p. 1, doi. 10.1177/17588359231221340
- By:
- Publication type:
- Article